Increased risk of hepatocellular carcinoma in viral hepatitis associated end-stage liver disease (ESLD).

被引：0
|
作者：
Perez, RG [1 ]
Zein, NN [1 ]
Steers, JL [1 ]
Wiesner, RH [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DEPT GASTROENTEROL & LIVER TRANSPLANTAT,ROCHESTER,MN 55905
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [41] Hepatitis C Viral Load, Genotype, and Increased Risk of Developing End-Stage Renal Disease: REVEAL-HCV Study
    Lai, Tai-Shuan
    Lee, Mei-Hsuan
    Yang, Hwai-I
    You, San-Lin
    Lu, Sheng-Nan
    Wang, Li-Yu
    Yuan, Yong
    L'Italien, Gilbert
    Chien, Kuo-Liong
    Chen, Chien-Jen
    HEPATOLOGY, 2017, 66 (03) : 784 - 793
  • [42] Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma
    Goldberg, David
    French, Benjamin
    Abt, Peter
    Feng, Sandy
    Cameron, Andrew M.
    LIVER TRANSPLANTATION, 2012, 18 (04) : 434 - 443
  • [43] MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma
    Li, Gang
    Cai, Guohong
    Li, Demin
    Yin, Wen
    POSTGRADUATE MEDICAL JOURNAL, 2014, 90 (1060) : 106 - 112
  • [44] TYPE 2 DIABETES MELLITUS AND HEPATOCELLULAR CARCINOMA ARE RISK FACTORS FOR HEPATIC ENCEPHALOPATHY IN PATIENTS WITH END-STAGE LIVER DISEASE
    Sundaram, Vinay
    Ganesh, Swaytha
    Behari, Jaideep
    HEPATOLOGY, 2010, 52 (04) : 911A - 912A
  • [45] Treatment in disproportionately minority hospitals is associated with an increased mortality in end-stage liver disease
    Brahmania, Mayur
    Alotaibi, Ammar
    Mooney, Owen
    Rush, Barret
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (11) : 1408 - 1413
  • [46] Increased anti-ARFP antibody positivity is associated with end-stage liver disease
    Walewski, Jose L.
    Gutierrez, Julio A.
    Klepper, Arielle
    Branch, Andrea D.
    HEPATOLOGY, 2006, 44 (04) : 278A - 278A
  • [47] A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol
    Patrik Nasr
    Mikael Forsgren
    Wile Balkhed
    Cecilia Jönsson
    Nils Dahlström
    Christian Simonsson
    Shan Cai
    Anna Cederborg
    Martin Henriksson
    Henrik Stjernman
    Martin Rejler
    Daniel Sjögren
    Gunnar Cedersund
    Wolf Bartholomä
    Ingvar Rydén
    Peter Lundberg
    Stergios Kechagias
    Olof Dahlqvist Leinhard
    Mattias Ekstedt
    BMC Gastroenterology, 23
  • [48] Role of the model for end-stage liver disease and serum α-fetoprotein as prognostic predictors for hepatocellular carcinoma
    Huo, Teh-Ia
    Lee, Shou-Dong
    LIVER INTERNATIONAL, 2006, 26 (10) : 1300 - 1301
  • [49] Management of End-Stage Liver Disease in Chronic Hepatitis B
    Tan, Hui-Hui
    Martin, Paul
    CLINICS IN LIVER DISEASE, 2010, 14 (03) : 477 - +
  • [50] Liver resection for hepatocellular carcinoma in patients with end-stage renal failure
    Cheng, SB
    Wu, CC
    Shu, KH
    Ho, WL
    Chen, JT
    Yeh, DC
    Liu, TJ
    P'eng, FK
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 78 (04) : 241 - 246
12345